Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 388

1.

Validation of cellular tests for Lyme borreliosis (VICTORY) study.

van de Schoor FR, Baarsma ME, Gauw SA, Joosten LAB, Kullberg BJ, van den Wijngaard CC, Hovius JW.

BMC Infect Dis. 2019 Aug 20;19(1):732. doi: 10.1186/s12879-019-4323-6.

2.

A Genome-Wide Functional Genomics Approach Identifies Susceptibility Pathways to Fungal Bloodstream Infection in Humans.

Jaeger M, Matzaraki V, Aguirre-Gamboa R, Gresnigt MS, Chu X, Johnson MD, Oosting M, Smeekens SP, Withoff S, Jonkers I, Perfect JR, van de Veerdonk FL, Kullberg BJ, Joosten LAB, Li Y, Wijmenga C, Netea MG, Kumar V.

J Infect Dis. 2019 Jul 31;220(5):862-872. doi: 10.1093/infdis/jiz206.

PMID:
31241743
3.

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.

Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P.

Crit Care. 2019 Jun 14;23(1):219. doi: 10.1186/s13054-019-2497-3.

4.

A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis.

Jaeger M, Pinelli M, Borghi M, Constantini C, Dindo M, van Emst L, Puccetti M, Pariano M, Ricaño-Ponce I, Büll C, Gresnigt MS, Wang X, Gutierrez Achury J, Jacobs CWM, Xu N, Oosting M, Arts P, Joosten LAB, van de Veerdonk FL, Veltman JA, Ten Oever J, Kullberg BJ, Feng M, Adema GJ, Wijmenga C, Kumar V, Sobel J, Gilissen C, Romani L, Netea MG.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaar3558. doi: 10.1126/scitranslmed.aar3558.

PMID:
31189718
5.

Quality indicators for appropriate outpatient parenteral antimicrobial therapy (OPAT) in adults: a systematic review and RAND-modified Delphi procedure.

Berrevoets MAH, Ten Oever J, Oerlemans AJM, Kullberg BJ, Hulscher ME, Schouten JA.

Clin Infect Dis. 2019 May 6. pii: ciz362. doi: 10.1093/cid/ciz362. [Epub ahead of print]

PMID:
31056690
6.

Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).

Vrijmoeth HD, Ursinus J, Harms MG, Zomer TP, Gauw SA, Tulen AD, Kremer K, Sprong H, Knoop H, Vermeeren YM, van Kooten B, Joosten LAB, Kullberg BJ, Hovius JWR, van den Wijngaard CC.

BMC Infect Dis. 2019 Apr 15;19(1):324. doi: 10.1186/s12879-019-3949-8.

7.

Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study.

Ham JC, Driessen CM, Hendriks MP, Fiets E, Kreike B, Hoeben A, Slingerland M, van Opstal CC, Kullberg BJ, Jonker MA, Adang EM, Kaanders JH, van der Graaf WT, van Herpen CM.

Eur J Cancer. 2019 May;113:32-40. doi: 10.1016/j.ejca.2019.02.013. Epub 2019 Apr 6.

PMID:
30965213
8.

Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.

Berende A, Ter Hofstede HJM, Vos FJ, Vogelaar ML, van Middendorp H, Evers AWM, Kessels RPC, Kullberg BJ.

Neurology. 2019 Mar 26;92(13):e1447-e1455. doi: 10.1212/WNL.0000000000007186. Epub 2019 Feb 22.

9.

18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle.

Berrevoets MAH, Kouijzer IJE, Slieker K, Aarntzen EHJG, Kullberg BJ, Oever JT, Bleeker-Rovers CP.

J Nucl Med. 2019 Jul;60(7):998-1002. doi: 10.2967/jnumed.118.221929. Epub 2018 Dec 14.

PMID:
30552202
10.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); European Society of Intensive Care Medicine (ESICM); European Confederation of Medical Mycology (ECMM); Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2019 Apr;62(4):310-319. doi: 10.1111/myc.12869. Epub 2019 Jan 22.

PMID:
30426598
11.

Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient's perspective: a qualitative study.

Berrevoets MAH, Oerlemans AJM, Tromp M, Kullberg BJ, Ten Oever J, Schouten JA, Hulscher ME.

BMJ Open. 2018 Nov 12;8(11):e024564. doi: 10.1136/bmjopen-2018-024564.

12.

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda L, Croos-Dabrera R, Fredericks C, Thompson GR.

Clin Infect Dis. 2019 May 30;68(12):1981-1989. doi: 10.1093/cid/ciy827.

PMID:
30289478
13.

A survey on antimicrobial stewardship prerequisites, objectives and improvement strategies: systematic development and nationwide assessment in Dutch acute care hospitals.

Kallen MC, Ten Oever J, Prins JM, Kullberg BJ, Schouten JA, Hulscher MEJL.

J Antimicrob Chemother. 2018 Dec 1;73(12):3496-3504. doi: 10.1093/jac/dky367.

PMID:
30252063
14.

Human resources required for antimicrobial stewardship teams: a Dutch consensus report.

Ten Oever J, Harmsen M, Schouten J, Ouwens M, van der Linden PD, Verduin CM, Kullberg BJ, Prins JM, Hulscher MEJL; SWAB Working Group on Antimicrobial Stewardship.

Clin Microbiol Infect. 2018 Dec;24(12):1273-1279. doi: 10.1016/j.cmi.2018.07.005. Epub 2018 Jul 20.

PMID:
30036665
15.

Invasive candidiasis.

Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ.

Nat Rev Dis Primers. 2018 May 11;4:18026. doi: 10.1038/nrdp.2018.26. Review.

PMID:
29749387
16.

Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.

Berende A, Nieuwenhuis L, Ter Hofstede HJM, Vos FJ, Vogelaar ML, Tromp M, van Middendorp H, Donders ART, Evers AWM, Kullberg BJ, Adang EMM.

PLoS One. 2018 Apr 2;13(4):e0195260. doi: 10.1371/journal.pone.0195260. eCollection 2018.

17.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

18.

Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).

Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, Degener JE, van de Garde EMW, Verheij TJ, Sachs APE, Prins JM.

Neth J Med. 2018 Jan;76(1):4-13.

19.

Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.

Davidson L, Netea MG, Kullberg BJ.

J Fungi (Basel). 2018 Jan 9;4(1). pii: E9. doi: 10.3390/jof4010009. Review.

20.

Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.

Goh JG, Ravikumar S, Win MS, Cao Q, Tan AL, Lim JHJ, Leong W, Herbrecht R, Troke PF, Kullberg BJ, Netea MG, Chng WJ, Dan YY, Chai LYA.

Cell Microbiol. 2018 Mar;20(3). doi: 10.1111/cmi.12798. Epub 2017 Dec 20.

PMID:
29088499
21.

An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study.

Berrevoets MAH, Pot JHLW, Houterman AE, Dofferhoff ATSM, Nabuurs-Franssen MH, Fleuren HWHA, Kullberg BJ, Schouten JA, Sprong T.

Antimicrob Resist Infect Control. 2017 Aug 15;6:81. doi: 10.1186/s13756-017-0239-3. eCollection 2017.

22.

Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry.

Berrevoets MA, Ten Oever J, Sprong T, van Hest RM, Groothuis I, van Heijl I, Schouten JA, Hulscher ME, Kullberg BJ.

BMC Infect Dis. 2017 Aug 15;17(1):565. doi: 10.1186/s12879-017-2673-5.

23.

An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility.

Matzaraki V, Gresnigt MS, Jaeger M, Ricaño-Ponce I, Johnson MD, Oosting M, Franke L, Withoff S, Perfect JR, Joosten LAB, Kullberg BJ, van de Veerdonk FL, Jonkers I, Li Y, Wijmenga C, Netea MG, Kumar V.

PLoS One. 2017 Jul 20;12(7):e0180824. doi: 10.1371/journal.pone.0180824. eCollection 2017.

24.

Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.

Leijtens B, Elbers JBW, Sturm PD, Kullberg BJ, Schreurs BW.

BMC Infect Dis. 2017 May 2;17(1):321. doi: 10.1186/s12879-017-2429-2.

25.

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.

Kullberg BJ, Vasquez J, Mootsikapun P, Nucci M, Paiva JA, Garbino J, Yan JL, Aram J, Capparella MR, Conte U, Schlamm H, Swanson R, Herbrecht R.

J Antimicrob Chemother. 2017 Aug 1;72(8):2368-2377. doi: 10.1093/jac/dkx116.

26.

Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses.

Leentjens J, Gresnigt MS, van de Veerdonk FL, Kox M, Kullberg BJ, Pickkers P, Brouwer AE, Netea MG.

Int J Infect Dis. 2017 Jun;59:25-28. doi: 10.1016/j.ijid.2017.03.013. Epub 2017 Mar 22.

27.

18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality.

Berrevoets MAH, Kouijzer IJE, Aarntzen EHJG, Janssen MJR, De Geus-Oei LF, Wertheim HFL, Kullberg BJ, Oever JT, Oyen WJG, Bleeker-Rovers CP.

J Nucl Med. 2017 Sep;58(9):1504-1510. doi: 10.2967/jnumed.117.191981. Epub 2017 Mar 23.

28.

Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA.

Intensive Care Med. 2017 Sep;43(9):1225-1238. doi: 10.1007/s00134-017-4731-2. Epub 2017 Mar 2. Review.

PMID:
28255613
29.

Functional and Genomic Architecture of Borrelia burgdorferi-Induced Cytokine Responses in Humans.

Oosting M, Kerstholt M, Ter Horst R, Li Y, Deelen P, Smeekens S, Jaeger M, Lachmandas E, Vrijmoeth H, Lupse M, Flonta M, Cramer RA, Kullberg BJ, Kumar V, Xavier R, Wijmenga C, Netea MG, Joosten LA.

Cell Host Microbe. 2016 Dec 14;20(6):822-833. doi: 10.1016/j.chom.2016.10.006. Epub 2016 Nov 3.

30.

Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

Kullberg BJ, Berende A, Evers AW.

N Engl J Med. 2016 Sep 8;375(10):998. doi: 10.1056/NEJMc1608044. No abstract available.

PMID:
27602673
31.

Understanding human immune function using the resources from the Human Functional Genomics Project.

Netea MG, Joosten LA, Li Y, Kumar V, Oosting M, Smeekens S, Jaeger M, Ter Horst R, Schirmer M, Vlamakis H, Notebaart R, Pavelka N, Aguirre-Gamboa RR, Swertz MA, Tunjungputri RN, van de Heijden W, Franzosa EA, Ng A, Graham D, Lassen K, Schraa K, Netea-Maier R, Smit J, de Mast Q, van de Veerdonk F, Kullberg BJ, Tack C, van de Munckhof I, Rutten J, van der Graaf J, Franke L, Hofker M, Jonkers I, Platteel M, Maatman A, Fu J, Zhernakova A, van der Meer JW, Dinarello CA, van der Ven A, Huttenhouwer C, Koenen H, Joosten I, Xavier RJ, Wijmenga C.

Nat Med. 2016 Aug 4;22(8):831-3. doi: 10.1038/nm.4140. No abstract available.

PMID:
27490433
32.

Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapy.

Arts P, van de Veerdonk FL, van der Lee R, Langereis MA, Gilissen C, van Zelst-Stams WAG, Huynen MA, van der Meer JWM, van Kuppeveld FJ, Veltman JA, Kullberg BJ, Hoischen A, Netea MG.

J Allergy Clin Immunol. 2016 Sep;138(3):895-898. doi: 10.1016/j.jaci.2016.02.025. Epub 2016 Apr 7. No abstract available.

PMID:
27132219
33.

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers AW, Kullberg BJ.

N Engl J Med. 2016 Mar 31;374(13):1209-20. doi: 10.1056/NEJMoa1505425.

34.

Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC.

Jaeger M, Carvalho A, Cunha C, Plantinga TS, van de Veerdonk F, Puccetti M, Galosi C, Joosten LA, Dupont B, Kullberg BJ, Sobel JD, Romani L, Netea MG.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):797-801. doi: 10.1007/s10096-016-2600-5. Epub 2016 Mar 7.

35.

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.

Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, van der Linden PD, Natsch S, Hertogh CMPM, Wolfs TFW, Schouten JA, Kullberg BJ, Prins JM.

Lancet Infect Dis. 2016 Jul;16(7):847-856. doi: 10.1016/S1473-3099(16)00065-7. Epub 2016 Mar 3. Review. Erratum in: Lancet Infect Dis. 2016 Jul;16(7):768.

PMID:
26947617
36.

Invasive Candidiasis.

Kullberg BJ, Arendrup MC.

N Engl J Med. 2016 Feb 25;374(8):794-5. doi: 10.1056/NEJMc1514201. No abstract available.

PMID:
26933864
37.

CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival.

Swamydas M, Gao JL, Break TJ, Johnson MD, Jaeger M, Rodriguez CA, Lim JK, Green NM, Collar AL, Fischer BG, Lee CC, Perfect JR, Alexander BD, Kullberg BJ, Netea MG, Murphy PM, Lionakis MS.

Sci Transl Med. 2016 Jan 20;8(322):322ra10. doi: 10.1126/scitranslmed.aac7718.

38.

Adoption of a national antimicrobial guide (SWAB-ID) in the Netherlands.

Schuts EC, van den Bosch CM, Gyssens IC, Kullberg BJ, Leverstein-van Hall MA, Natsch S, Sebens F, Adams MB, Drew R, Prins JM.

Eur J Clin Pharmacol. 2016 Feb;72(2):249-52. doi: 10.1007/s00228-015-1969-x. Epub 2015 Oct 22. No abstract available.

PMID:
26494129
39.

Invasive Candidiasis.

Kullberg BJ, Arendrup MC.

N Engl J Med. 2015 Oct 8;373(15):1445-56. doi: 10.1056/NEJMra1315399. Review. No abstract available.

PMID:
26444731
40.

Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders.

ten Oever J, Netea MG, Kullberg BJ.

J Infect. 2016 Jan;72(1):1-18. doi: 10.1016/j.jinf.2015.09.007. Epub 2015 Sep 30. Review.

PMID:
26429736
41.

Immune defence against Candida fungal infections.

Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL.

Nat Rev Immunol. 2015 Oct;15(10):630-42. doi: 10.1038/nri3897. Epub 2015 Sep 21. Review.

PMID:
26388329
42.

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, Kullberg BJ, Lagrou K, Maertens J, Meis JF, Newton P, Page I, Seyedmousavi S, Sheppard DC, Viscoli C, Warris A, Donnelly JP.

Drug Resist Updat. 2015 Jul-Aug;21-22:30-40. doi: 10.1016/j.drup.2015.08.001. Epub 2015 Aug 7.

43.

Identifying targets for quality improvement in hospital antibiotic prescribing.

van Spreuwel PC, Blok H, Langelaar MF, Kullberg BJ, Mouton JW, Natsch S.

Neth J Med. 2015 May;73(4):161-8.

44.

Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis.

Delsing CE, Becker KL, Simon A, Kullberg BJ, Bleeker-Rovers CP, van de Veerdonk FL, Netea MG.

BMC Infect Dis. 2015 Mar 21;15:140. doi: 10.1186/s12879-015-0891-2.

45.

The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infections.

Jaeger M, van der Lee R, Cheng SC, Johnson MD, Kumar V, Ng A, Plantinga TS, Smeekens SP, Oosting M, Wang X, Barchet W, Fitzgerald K, Joosten LAB, Perfect JR, Wijmenga C, van de Veerdonk FL, Huynen MA, Xavier RJ, Kullberg BJ, Netea MG.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):963-974. doi: 10.1007/s10096-014-2309-2. Epub 2015 Jan 13.

46.

The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases.

Ten Oever J, Kox M, van de Veerdonk FL, Mothapo KM, Slavcovici A, Jansen TL, Tweehuysen L, Giamarellos-Bourboulis EJ, Schneeberger PM, Wever PC, Stoffels M, Simon A, van der Meer JW, Johnson MD, Kullberg BJ, Pickkers P, Pachot A, Joosten LA, Netea MG.

BMC Immunol. 2014 Nov 19;15:55. doi: 10.1186/s12865-014-0055-y.

47.

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.

Berende A, ter Hofstede HJ, Donders AR, van Middendorp H, Kessels RP, Adang EM, Vos FJ, Evers AW, Kullberg BJ.

BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.

48.

Immunotherapy: a potential adjunctive treatment for fungal infection.

Kullberg BJ, van de Veerdonk F, Netea MG.

Curr Opin Infect Dis. 2014 Dec;27(6):511-6. doi: 10.1097/QCO.0000000000000105. Review.

PMID:
25304393
49.

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis.

Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, Venselaar H, Joosten LA, van der Meer JW, Dupont B, Kullberg BJ, Sobel JD, Netea MG.

Front Microbiol. 2014 Sep 23;5:483. doi: 10.3389/fmicb.2014.00483. eCollection 2014.

50.

Human TLR10 is an anti-inflammatory pattern-recognition receptor.

Oosting M, Cheng SC, Bolscher JM, Vestering-Stenger R, Plantinga TS, Verschueren IC, Arts P, Garritsen A, van Eenennaam H, Sturm P, Kullberg BJ, Hoischen A, Adema GJ, van der Meer JW, Netea MG, Joosten LA.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4478-84. doi: 10.1073/pnas.1410293111. Epub 2014 Oct 6.

Supplemental Content

Loading ...
Support Center